Curcumin-3,4-Dichloro Phenyl Pyrazole (CDPP) overcomes curcumins low bioavailability, inhibits adipogenesis and ameliorates dyslipidemia by activating reverse cholesterol transport
Combining two agents that each need their own titration stacks those dose-related effects, and no monitored study has characterised where the resulting ceiling sits
It is provided for scientific and informational purposes and does not constitute a recommendation for individual use, medical advice or administration instructions
Studies focusing on IBS have shown that circulating 5-HT levels rise after a meal, and that this rise is exaggerated in IBS with diarrhea and suppressed in IBS with constipation (112, 113)
What Does the Research Tell Us about BPC-157
Consult a licensed provider before treatment if you are pregnant or breastfeeding, have significant liver or kidney disease, have a history of allergies to any ingredient (including B12/cobalt), are taking other medications, or have unmanaged medical conditions